Moreover, tumor-infiltrating CD8+ effector T cells were more efficiently activated by VV-iPDL1/GM injections, as manifested by an enhanced expression of IFN-γ, TNF-α, and CD107a in response to the stimulation with tumor lysate-pulsed DCs (Fig. 5d, e). The gene discussed is CD8A; the disease is neoplasm.